Literature DB >> 1911200

Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck.

J K Field1, D A Spandidos, A Malliri, J R Gosney, M Yiagnisis, P M Stell.   

Abstract

Expression of the tumour suppressor gene p53 was examined in squamous cell carcinoma of the head and neck using two p53 antibodies, PAb 421 and PAb 1801. Elevated p53 expression was found in 67% of the 73 patients investigated. P53 expression was not found to correlate with whether the patient had been previously treated or not, nor any of the clinico-pathological parameters. However a correlation was found between the patients smoking history and positive p53 staining. Six out of seven non-smokers did not express p53 whereas 29 of 37 heavy smokers were found to have elevated p53 expression (P less than 0.005). Also, of a group of ten patients who had given up smoking more than 5 years ago, nine had elevated expression. Epidemiological studies have shown a correlation between heavy smoking and head and neck cancer. The present study indicate a genetic link for this correlation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911200      PMCID: PMC1977652          DOI: 10.1038/bjc.1991.352

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  The p53 proto-oncogene can act as a suppressor of transformation.

Authors:  C A Finlay; P W Hinds; A J Levine
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

2.  Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

Authors:  L Banks; G Matlashewski; L Crawford
Journal:  Eur J Biochem       Date:  1986-09-15

3.  Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.

Authors:  J Bartek; R Iggo; J Gannon; D P Lane
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

4.  Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.

Authors:  E Harlow; N M Williamson; R Ralston; D M Helfman; T E Adams
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

5.  P53 expression in breast cancer.

Authors:  G Cattoretti; F Rilke; S Andreola; L D'Amato; D Delia
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

6.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

Authors:  S J Baker; E R Fearon; J M Nigro; S R Hamilton; A C Preisinger; J M Jessup; P vanTuinen; D H Ledbetter; D F Barker; Y Nakamura; R White; B Vogelstein
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

7.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

8.  Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.

Authors:  J K Field; D A Spandidos; P M Stell; E D Vaughan; G I Evan; J P Moore
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

9.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

Authors:  L F Parada; H Land; R A Weinberg; D Wolf; V Rotter
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

10.  Oncogene amplification in squamous cell carcinoma of the oral cavity.

Authors:  D Saranath; R G Panchal; R Nair; A R Mehta; V Sanghavi; J Sumegi; G Klein; M G Deo
Journal:  Jpn J Cancer Res       Date:  1989-05
View more
  32 in total

1.  p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts.

Authors:  G R Ogden; D M Chisholm; R A Kiddie; D P Lane
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

2.  P53 expression in stage I squamous cell lung cancer.

Authors:  J Moldvay; J Strausz; M Egerváry; L Agócs; J Bocsi; Z Schaff
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

Review 3.  Per[cyst]ent growth: the odontogenic keratocyst 40 years on.

Authors:  R M Browne
Journal:  Ann R Coll Surg Engl       Date:  1996-09       Impact factor: 1.891

Review 4.  The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma.

Authors:  J K Field
Journal:  J R Soc Med       Date:  1995-01       Impact factor: 5.344

5.  Nuclear DNA content and p53 overexpression in stage I squamous cell carcinoma of the tongue compared with advanced tongue carcinomas.

Authors:  A Högmo; R Kuylenstierna; J Lindholm; A Nathansson; G Auer; E Munck-Wikland
Journal:  Mol Pathol       Date:  1998-10

6.  p53 alterations in human squamous cell carcinomas and carcinoma cell lines.

Authors:  J Caamano; S Y Zhang; E A Rosvold; B Bauer; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 7.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

8.  Mechanisms of oral carcinogenesis induced by dibenzo[a,l]pyrene: an environmental pollutant and a tobacco smoke constituent.

Authors:  Kun-Ming Chen; Joseph B Guttenplan; Shang-Min Zhang; Cesar Aliaga; Timothy K Cooper; Yuan-Wan Sun; Joseph DelTondo; Wieslawa Kosinska; Arun K Sharma; Kun Jiang; Richard Bruggeman; Kwangmi Ahn; Shantu Amin; Karam El-Bayoumy
Journal:  Int J Cancer       Date:  2013-04-22       Impact factor: 7.396

9.  Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene.

Authors:  B Ruggeri; M DiRado; S Y Zhang; B Bauer; T Goodrow; A J Klein-Szanto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

10.  Biomolecular markers in cancer of the tongue.

Authors:  Daris Ferrari; Carla Codecà; Jessica Fiore; Laura Moneghini; Silvano Bosari; Paolo Foa
Journal:  J Oncol       Date:  2009-08-19       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.